The size of the Radiotherapy Market in Latin America was worth USD 0.78 billion in 2022 and is estimated to be growing at a CAGR of 6.54% to reach USD 1.07 billion by 2027.
Radiotherapy is generally applied to cancerous tumors because of its proficiency in controlling cell division. It is also used to treat benign tumors and other diseases like some blood disorders and thyroid disease. Nearly half of the cancer patients are being cured by radiation therapy.
The radiation therapy market has been expanding at a healthy pace for the past few years because of increasing cancer cases and a rise in the sophistication of novel treatment procedures. Moreover, Reimbursement levels for radiation therapy and replacements of older radiotherapy systems are few factors augmenting the growth of the radiotherapy market.
The major problems faced by the market involve stringent regulations and expensive treatments.
This research report on the Latin American Radiotherapy market has been segmented and sub-segmented into the following categories:
By Equipment Type:
Mexico is the dominant market in the Latin America region and is expected to continue its dominance over the forecast period.
KEY MARKET PLAYERS:
Some of the noteworthy companies operating in the Latin American radiotherapy market profiled in this report are Nordion Inc., RaySearch Laboratories AB, Ion Beam Applications SA, C. R. Bard Inc., Mevion Medical Systems Inc., Varian Medical Systems Inc., IsoRay Medical Inc., Elekta AB, Accuray Incorporated and Mitsubishi Electric Corporation.
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: firstname.lastname@example.org